Please login to the form below

Not currently logged in
Email:
Password:

Pharma market

This page shows the latest Pharma market news and features for those working in and with pharma, biotech and healthcare.

AZ taps Ionis for another drug, this time in NASH

AZ taps Ionis for another drug, this time in NASH

and an untapped pharma market as there are as yet no approved treatments. ... We look forward to AZ moving this programme swiftly into clinical testing and ultimately to the market.”.

Latest news

  • BMS gets OK for monthly Opdivo dosing BMS gets OK for monthly Opdivo dosing

    BMS gets OK for monthly Opdivo dosing. Analysts predict the new dosing schedule could see the pharma giant win market share. ... posting 2017 revenues from the drug of $3.8bn, thanks in part to its leading position in the big NSCLC market.

  • Amazon’s invasion Amazon’s invasion

    Unless you have been blindfolded with your fingers in your ears, you can’t have missed the fuss about Amazon entering the pharma market as a new channel. ... To discount the threat of Amazon, even if it hasn’t entered your market yet, would be naïve.

  • AZ pushes harder into China with new joint venture AZ pushes harder into China with new joint venture

    AstraZeneca has signed another deal to help it unlock the Chinese pharma market, setting up a new joint venture company to bring its drugs to market there more quickly. ... Other investments by AZ in China - now the second-largest pharma market in the

  • Boehringer builds evidence base for its Humira biosimilar Boehringer builds evidence base for its Humira biosimilar

    Usually, a CHMP opinion would be a big confidence boost to a pharma firm looking to market its product in the EU, however Boehringer and AbbVie are currently locked in US ... In the US AbbVie wants to keep Cyltezo off the market, claiming it will

  • Boehringer bolsters NASH pipeline with $201m Dicerna deal Boehringer bolsters NASH pipeline with $201m Dicerna deal

    It stands to receive $201m in upfront and milestone payments from the privately-held German pharma group, plus royalties on any eventual sales. ... health crisis - and an untapped pharma market.

More from news
Approximately 1 fully matching, plus 309 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    But PUSH incentives are not enough to fix the problem with the antibiotics market. ... For biotechs, pharma companies and their investors, there must be progress on the market PULL side of the equation.

  • A marathon and a sprint A marathon and a sprint

    It seems some pharma companies are not quite out of the starting blocks. ... That can easily translate to pharma; medical can own some touchpoints, market access likewise and so on.

  • Pharma’s coral reef Pharma’s coral reef

    When a concept from an academic lab is turned into a therapy by a biotech, that works with big pharma to bring it to market, and then contracts out its manufacture ... and work with another big pharma to market it across the globe, that is a holobiont.

  • Multichannel in pharma Multichannel in pharma

    A strong growth in online pharma channel reach (pharma websites have jumped from 25% to 45% reach). ... Also, in any market where pharma’s digital ‘supply’grows, physicians are becoming more satisfied.

  • Can big data give medical affairs an edge in strategic planning? Can big data give medical affairs an edge in strategic planning?

    It is also a powerful way to track new discoveries, research trends and shifts in the market place, so that pharma can understand what’s happening and adjust its future objectives ... Digital inspiration for pharma on mobile, social media, strategy,

More from intelligence
Approximately 0 fully matching, plus 68 partially matching documents found.

Latest appointments

  • Janssen's Matthew Kirby takes up senior role at Wilmington Healthcare Janssen's Matthew Kirby takes up senior role at Wilmington Healthcare

    Having spent many years working in the pharma industry in sales, market access and business development roles, Matthew has a wealth of knowledge and experience, and he will be a very ... Before joining Janssen Kirby was at Nycomed Pharmaceuticals, where

  • Bayer UK and Ireland appoints new CEO Bayer UK and Ireland appoints new CEO

    Bayer has appointed a new UK and Ireland CEO in the form of Lars Bruening, who moves to its Reading, UK base from Berlin where he was head of the pharma ... He said: “Looking in from afar, the progress the UK and Ireland has made over the last four

  • Medmeme bolsters its sales team Medmeme bolsters its sales team

    Mahesh Naithani, founder of Medmeme, said: “Franco is ideally placed to drive sales for Medmeme’s unique offering which can yield transformative and market-differentiating benefits for pharma and other healthcare

  • MRN expands operations with new senior director MRN expands operations with new senior director

    He said: “ In my previous role, I was becoming more and more aware and interested in the growing role home healthcare and how it revolutionising both the pharma industry and health ... outcomes. “ MRN is the market leader and working with pharma

  • PharmaVentures adds to business development team PharmaVentures adds to business development team

    PharmaVentures has appointed Graham Combe to its business development team. Combe has over 18 years of experience in business development within the pharma and biotech industries, as well as the media ... Previously, Combe ran his own business, Biosell,

More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

  • Article: The Art of Storytelling in Pharma Market Research

    Article: The Art of Storytelling in Pharma Market Research. Published in PBIRG Perspective, May 2016, vol. ... 18 No.1, By Julie Denny, Marketing Director. Storytelling – it’ s the (not so) new buzzword in pharma market research.

  • Pharma Market Research Conference

    Pharma Market Research Conference. he European Pharma Market Research Conference is your exclusive entry into the world of pharmaceutical market research with a focus on Europe, yet also considering the global ... Pharma Market Research Conference.

  • Article: The Art of Storytelling in Pharma Market Research

    Article: The Art of Storytelling in Pharma Market Research. Published in PBIRG Perspective, May 2016, vol. ... 18 No.1, By Julie Denny, Marketing Director. Storytelling – it’ s the (not so) new buzzword in pharma market research.

  • A roadmap to strategic drug pricing

    A roadmap to strategic drug pricing. The current unit-based pricing model for drugs is too one-dimensional for the market's present needs. ... Pharma firms must identify products that will benefit from innovative pricing models, and then forge the types

  • Pharma Market Research Conference, 2018

    Pharma Market Research Conference, 2018. We are delighted to be presenting and exhibiting at PMRC, 14-15 February in Newark, NJ.

More from PMHub
Approximately 1 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics